View Older Stories View More Recent Stories

Apr 28, 2026 09:07AM UBS Reiterates Buy Rating on CG Oncology (CGON) as AUA 2026 Abstracts Released

Apr 27, 2026 05:39AM CG Oncology (CGON) PT Raised to $79 at RBC Capital

Apr 13, 2026 08:47AM CG Oncology appoints Jim DeTore as chief financial officer

Apr 7, 2026 05:50AM CG Oncology (CGON) PT Raised to $100 at H.C. Wainwright

Mar 26, 2026 09:16AM CG Oncology (CGON) PT Raised to $90 at UBS

Mar 13, 2026 03:34PM Truist Securities Reiterates Buy Rating on CG Oncology (CGON) following JNJ erda-i data presentation

Mar 13, 2026 03:31PM CG Oncology (CGON) PT Raised to $72 at BofA Securities

Mar 2, 2026 06:59AM CG Oncology (CGON) PT Raised to $80 at H.C. Wainwright

Feb 10, 2026 06:16AM CG Oncology (CGON) PT Raised to $75 at Truist Securities

Jan 12, 2026 09:29AM CG Oncology (CGON) PT Raised to $66 at Truist; 'Creto in Full Speed'

Jan 9, 2026 02:26PM CG Oncology (CGON) PT Raised to $93 at Morgan Stanley

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 11, 2025 06:42AM Wedbush Starts CG Oncology (CGON) at Outperform

Nov 26, 2025 07:01AM CG Oncology adds Christina Rossi to board, Simone Song resigns

Nov 24, 2025 07:32AM Truist Securities Starts CG Oncology (CGON) at Buy

Nov 17, 2025 07:52AM CG Oncology (CGON) PT Raised at RBC Capital; 'Data Catalyts in 4Q25 Can Drive Upside'

Nov 14, 2025 05:06PM CG Oncology, Inc. (CGON) Reports Q3 Loss of $0.57

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Oct 8, 2025 05:35AM Guggenheim Starts CG Oncology (CGON) at Buy

Sep 15, 2025 07:32AM H.C. Wainwright Reiterates Buy Rating on CG Oncology (CGON)

Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'

Sep 8, 2025 08:10AM Jones Trading Starts CG Oncology (CGON) at Buy, PT $50

Sep 8, 2025 07:14AM H.C. Wainwright Reiterates Buy Rating on CG Oncology (CGON)

Sep 5, 2025 07:02AM CG Oncology reports 41.8% complete response rate at 24 months

Sep 3, 2025 08:01AM CG Oncology completes enrollment in phase 3 bladder cancer study

Aug 19, 2025 06:13AM Piper Sandler Starts CG Oncology (CGON) at Overweight

Jul 29, 2025 04:09PM CG Oncology wins court case, avoids 5% royalty to ANI Pharmaceuticals

Jul 16, 2025 12:00PM CG Oncology (CGON) PT Lowered to $53 at RBC Capital

Jul 10, 2025 06:24AM Goldman Sachs Resumes CG Oncology (CGON) at Buy

Jun 17, 2025 05:59AM CG Oncology (CGON) PT Raised to $56 at Morgan Stanley

May 13, 2025 08:05AM CG Oncology, Inc. (CGON) Reports Q1 Loss of $0.45

May 2, 2025 02:47AM JPMorgan Starts CG Oncology (CGON) at Overweight

Apr 29, 2025 09:43AM UBS Reiterates Buy Rating on CG Oncology (CGON)

Apr 28, 2025 07:22AM CG Oncology (CGON) Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec

Apr 28, 2025 07:20AM Cantor Fitzgerald Reiterates Overweight Rating on CG Oncology (CGON)

Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald

Mar 31, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on CG Oncology (CGON)

Mar 25, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on CG Oncology (CGON)

Mar 24, 2025 08:04AM CG Oncology (CGON) Announces Cretostimogene Grenadenorepvec Data Continued to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy

Jan 7, 2025 05:33AM TD Cowen Starts CG Oncology (CGON) at Buy

Dec 11, 2024 06:18AM CG Oncology (CGON) Announces Proposed 7.3M Share Offering

Dec 6, 2024 06:45AM H.C. Wainwright Reiterates Buy Rating on CG Oncology (CGON)

Nov 12, 2024 05:22PM CG Oncology, Inc. (CGON) Tops Q3 EPS by 12c

Oct 24, 2024 03:49AM UBS Starts CG Oncology (CGON) at Buy

Oct 21, 2024 06:06AM Goldman Sachs Reiterates Buy Rating on CG Oncology (CGON)

Sep 26, 2024 10:45AM Goldman Sachs Reiterates Buy Rating on CG Oncology (CGON)

Sep 17, 2024 06:49AM H.C. Wainwright Reiterates Buy Rating on CG Oncology (CGON)

Sep 16, 2024 05:03AM Goldman Sachs Reiterates Buy Rating on CG Oncology (CGON)

Aug 27, 2024 04:04PM Roth/MKM Starts CG Oncology (CGON) at Buy

Jun 28, 2024 09:32AM BofA Securities Starts CG Oncology (CGON) at Buy

View More Recent Stories View Older Stories